American Cannabis Company, Inc.
AMMJ · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.04 | -0.00 | 0.00 |
| FCF Yield | 2.55% | -0.51% | 17.24% | -5.62% |
| EV / EBITDA | -4.39 | -62.34 | -0.94 | -58.90 |
| Quality | ||||
| ROIC | -171.88% | -13.10% | -273.71% | -4.97% |
| Gross Margin | -70.16% | 41.36% | 42.77% | 41.46% |
| Cash Conversion Ratio | -0.05 | 0.09 | -0.09 | 1.25 |
| Growth | ||||
| Revenue 3-Year CAGR | -38.80% | -9.89% | 0.29% | 88.62% |
| Free Cash Flow Growth | 372.59% | -103.92% | 280.77% | -527.99% |
| Safety | ||||
| Net Debt / EBITDA | -1.94 | -20.63 | -0.38 | -17.73 |
| Interest Coverage | -6.75 | -17.22 | -154.66 | -4.50 |
| Efficiency | ||||
| Inventory Turnover | 2.77 | 0.22 | 0.27 | 0.68 |
| Cash Conversion Cycle | -83.49 | -197.64 | -162.39 | -76.42 |